|March 2013 · Vol. 25, No. 3
UPDATE ON BREAST HEALTH
A look at findings from the estrogen-alone arm of the WHI,
chemoprophylaxis for high-risk women, and fertility preservation
for young breast cancer survivors
Dr. Pearlman is S. Jan Behrman Professor, Vice Chair, and Service Chief, Department of Obstetrics and Gynecology, and Professor, Department of Surgery, University of Michigan Medical School, Ann Arbor, Michigan. He is also Associate Chief of Clinical Affairs and Medical Director of Pharmacy, University of Michigan Hospital and Health Systems.
Dr. Griffin is Assistant Professor, Department of Obstetrics and Gynecology, University of Nebraska College of Medicine, Omaha, Nebraska.
The authors report no financial relationships relevant to this article.
The effects of breast cancer on obstetric and gynecologic practices are pervasive. In this article, we touch on three aspects of breast cancer that are particularly relevant to the practicing ObGyn: